Audrey Greenberg
Founder, Center for Breakthrough Medicines
and Global Head of Marketing and Communications, SK pharmteco
2024-09-03
We have made significant strides in reducing our greenhouse gas emissions by 35% in recent years and are committed to achieving net zero carbon emissions by 2040 across all Scope 1, 2, and 3 emissions. This goal involves a comprehensive approach focusing on three main areas: increasing energy efficiency while continuing to invest in green technologies, sourcing our electricity through renewable energy sources, like solar and wind, and supporting carbon compensation programs.